The affected product is used as a nasal decongestant and is packaged in a 0.5 fluid ounce bottle. The lot number is 173089J with an expiration date of September 2019.
“Repetitive use of a nasal spray containing a gram-negative pathogen can potentially lead to colonization and subsequent infection which can be life-threatening in certain patient populations, such as those with cystic fibrosis or immuno-compromised,” the recall states.
So far, Quest said it hasn’t received any reports of adverse events linked to the contaminated product.
More articles on pharmacy:
Teva’s revenue drops 18% in Q2
Express Scripts to drop coverage of 48 drugs next year
Trump to make drug price announcement next week
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
